-transparent.png){kind=logo}
Bloodstream infections with staphylococci are accompanied by thromboembolic complications. We have studied the mechanism of the interaction of staphylococci with human blood platelets. Staphylococci that possess protein A, a bacterial receptor for the Fc fragment of immunoglobulin G (IgG), caused aggregation of human platelets in whole plasma accompanied by release of [(3)H]serotonin. These reactions were time and concentration dependent, requiring two or more staphylococci per platelet to give maximal response within 5 min. The interaction between staphylococci and platelets required the presence of cell wall-bound protein A and of IgG with an intact Fc fragment. It did not require an intact complement system. Cell wall-bound protein A (solid phase) was capable of aggregating human platelets in whole plasma. In contrast, free, solubilized protein A (fluid phase) did not cause measurable aggregation, and release of [(3)H]serotonin was reduced. An excess of free, solubilized protein A blocked aggregation of human platelets induced by staphylococci in whole plasma. The role of the Fc fragment of IgG in the staphylococci-human platelet interaction was demonstrated by an experiment in which free, isolated Fc fragment blocked aggregation of platelets in whole plasma induced by staphylococci. Furthermore, binding of (125)I-protein A to human platelets was demonstrated in the presence of complete IgG with intact Fc fragment but not in the presence of the F(ab)(2) fragment. Binding of the protein A-IgG complex to the human platelet Fc receptor was paralleled by the release of [(3)H]serotonin. These results represent a novel example of the interaction of two phylogenetically different Fc receptors, one on prokaryotic staphylococci and the other on human platelets. Their common ligand, IgG, is amplified by one Fc receptor (protein A) to react with another Fc receptor present on human platelets, which results in membrane-mediated aggregation and release reaction occurring in whole plasma. This mechanism can be of significance in the pathomechanism of thromboembolic complications at the site(s) of intravascular staphylococcal infection.
J Hawiger, and
S Steckley, and
D Hammond, and
C Cheng, and
S Timmons, and
A D Glick, and
R M Des Prez
December 1985,
The Journal of clinical investigation,
J Hawiger, and
S Steckley, and
D Hammond, and
C Cheng, and
S Timmons, and
A D Glick, and
R M Des Prez
November 1971,
Immunochemistry,
J Hawiger, and
S Steckley, and
D Hammond, and
C Cheng, and
S Timmons, and
A D Glick, and
R M Des Prez
January 1981,
Postepy higieny i medycyny doswiadczalnej,
J Hawiger, and
S Steckley, and
D Hammond, and
C Cheng, and
S Timmons, and
A D Glick, and
R M Des Prez
January 1980,
Thrombosis research,
J Hawiger, and
S Steckley, and
D Hammond, and
C Cheng, and
S Timmons, and
A D Glick, and
R M Des Prez
July 1986,
The Journal of general virology,
J Hawiger, and
S Steckley, and
D Hammond, and
C Cheng, and
S Timmons, and
A D Glick, and
R M Des Prez
November 1990,
Scandinavian journal of clinical and laboratory investigation,
J Hawiger, and
S Steckley, and
D Hammond, and
C Cheng, and
S Timmons, and
A D Glick, and
R M Des Prez
January 1982,
The Journal of clinical investigation,
J Hawiger, and
S Steckley, and
D Hammond, and
C Cheng, and
S Timmons, and
A D Glick, and
R M Des Prez
May 1967,
Nature,
J Hawiger, and
S Steckley, and
D Hammond, and
C Cheng, and
S Timmons, and
A D Glick, and
R M Des Prez
April 1988,
Proceedings of the National Academy of Sciences of the United States of America,
J Hawiger, and
S Steckley, and
D Hammond, and
C Cheng, and
S Timmons, and
A D Glick, and
R M Des Prez
January 1995,
Infection and immunity,
